Genomic and non-genomic effects of glucocorticoids



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The overview describes the structure of a classic nuclear glucocorticoid receptor associated bound in inactive form to proteins chaperone complex. We analyzed genomic mechanisms regulated the gene expression, as well as a fastacting glucocorticoid effects of not genomic nature.

Full Text

Restricted Access

About the authors

N. M Todosenko

Immanuel Kant Baltic Federal University

Kaliningrad, Russia

Yu. A Koroleva

Immanuel Kant Baltic Federal University

Kaliningrad, Russia

O. G Khaziakhmatova

Immanuel Kant Baltic Federal University

Kaliningrad, Russia

K. A Yurova

Immanuel Kant Baltic Federal University

Kaliningrad, Russia

L. S Litvinova

Immanuel Kant Baltic Federal University

Kaliningrad, Russia

References

  1. Jiang Ch.L., Liu L., Li Zh. et al. The novel strategy of glucocorticoid drug development via targeting nongenomic mechanisms. Steroids 2015; 102: 27-31.
  2. Adcock I.M., Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunology and Cell Biology 2001; 79(4): 376-84.
  3. Garcia-Magallon B., Silva-Fernandez L., Andreu-Sanchez J.L. et al. Update on the Use of Steroids in Rheumatoid Arthritis. Reumatol. Clin. 2013; 9(5): 297-302.
  4. Saleh K.J., Kurdi A.J., El-Othmani M.M. et al. Perioperative Treatment of Patients with Rheumatoid Arthritis. J. Am. Acad. Orthop. Surg. 2015; 23(9): 38-48.
  5. Zampeli E., Vlachoyiannopoulos P.G., Tzioufas A.G. Treatment of rheumatoid arthritis: Unraveling the conundrum. Journal of Autoimmunity 2015; 65: 1-18.
  6. Black R.J., Joseph R.M., Brown B. et al. Half of UK patients with rheumatoid arthritis are prescribed oral glucocorticoid therapy in primary care: a retrospective drug utilisation study. Arthritis Research & Therapy 2015; 17: 375.
  7. Oppong E., Cato A.C.B. Effects of Glucocorticoids in the Immune System. In: Wang J.C., Harris Ch., editors. Glucocorticoid signaling from molecules to mice to man. Advances in Experimental Medicine and Biology. New York: Springer; 2015. p. 217-33.
  8. John K., Marino J.S., Sanchez E.R. et al. The glucocorticoid receptor: cause of or cure for obesity? Am. J. Physiol. Endocrinol. Metab. 2016; 310(4): 249-57.
  9. Cruz-Topete D., Cidlowski J.A. One hormone, two actions: anti- and pro-Inflammatory effects of glucocorticoids. Neuroimmunomodulation 2015; 22(1-2): 20-32.
  10. Baschant U., Tuckermann J. The role of the glucocorticoid receptor in inflammation and immunity. Journal of Steroid Biochemistry & Molecular Biology 2010; 120(2-3): 69-75.
  11. Revollo J.R., Cidlowski J.A. Mechanisms generating diversity in glucocorticoid receptor signaling. Glucocorticoids and Mood: Ann. N.Y. Acad. Sci. 2009; 1179: 167-78.
  12. Ratman D., Berghe W.V., Dejager L. et al. How glucocorticoid receptors modulate the activity of other transcription factors: A scope beyond tethering. Molecular and Cellular Endocrinology 2013; 380(1-2): 41-54.
  13. Bazso A., Szappanos A., Patocs A. et al. The importance of glucocorticoid receptors in systemic lupus erythaematosus. A systematic review. Autoimmun. Rev. 2015; 14(4): 349-51.
  14. Ayroldi E., Macchiarulo A., Riccardi C. Targeting glucocorticoid side effects: selective glucocorticoid receptor modulator or glucocorticoidinduced leucine zipper? A perspective. Faseb J. 201 4; 28(12): 5055-70.
  15. Hartmann K., Koenen M., Schauer S. et al. Molecular Actions of Glucocorticoids in Cartilage and Bone During Health, Disease, and Steroid Therapy. Physiol. Rev. 2016; 96(2): 409-47.
  16. Silverman M.N., Sternberg E.M. Glucocorticoid regulation of inflammation and its functional correlates: from HPA axis to glucocorticoid receptor dysfunction. Ann. N.Y. Acad. Sci. 2012; 1261: 55-63.
  17. Ingawale D.K., Mandlik S.K., Patel S.S. An emphasis on molecular mechanisms of anti-inflammatory effects and glucocorticoid resistance. J. Complement Integr. Med. 2015; 12(1): 1-13.
  18. Bamberger C.M., Bamberger A.M., de Castro M. et al. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J. Clin. Invest. 1995; 95(6): 2435-41.
  19. Nicolaides N.C., Galata Z., Kino T. et al. The human glucocorticoid receptor: molecular basis of biologic function. Steroids 2010; 75(1): 1-12.
  20. Oakley R.H., Sar M., Cidlowski J.A. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J. Biol. Chem. 1996; 271(16): 9550-9.
  21. Ray D.W., Davis J.R., White A. et al. Glucocorticoid receptor structure and function in glucocorticoid-resistant small cell lung carcinoma cells. Cancer Res. 1996; 56(14): 3276-80.
  22. Kelly A., Bowen H., Jee Y.K. et al. The glucocorticoid receptor beta isoform can mediate transcriptional repression by recruiting histone deacetylases. J. Allergy Clin. Immunol. 2008; 121(1): 203-8.
  23. Kim S.H., Kim D.H., Lavender P. et al. Repression of TNF -а-induced IL-8 expression by the glucocorticoid receptor involves inhibition of histone H4 acetylation. Exp. Mol. Med. 2009; 41(5): 297-306.
  24. Li L.B., Leung D.Y.M., Martin R.J. et al. Inhibition of histone deacetylase 2 expression by elevated glucocorticoid receptor in steroid-resistant asthma. Am. J. Respir. Crit. Care Med. 2010; 182(7): 877-83.
  25. Lui J.C., Nilsson O., Baron J. Growth plate senescence and catch-up growth. Endocr. Dev. 2011; 21: 23-9.
  26. Grad I., Picard D. The glucocorticoid responses are shaped by molecular chaperones. Mol. Cell Endocrinol. 2007; 275(1-2): 2-12.
  27. Pratt W.B. The role of heat shock proteins in regulating the function, folding, and trafficking of the glucocorticoid receptor. J. Biol. Chem. 1993; 268(29): 21455-8.
  28. Pratt W.B., Toft D.O. Regulation of signaling protein function and trafficking by the hsp90/hsp70-based chaperone machinery. Exp. Biol. Med. 2003; 228(2): 111-33.
  29. Pratt W.B., Toft D.O. Steroid receptor interactions with heat shock protein and immunophilin chaperones. Endocr. Rev. 1997; 18(3): 306-60.
  30. Riggs D.L., Roberts P.J., Chirillo S.C. et al. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo. EMBO J. 2003; 22(5): 1158-67.
  31. Vermeer H., Hendriks-Stegeman B.I., van der Burg B. et al. Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J. Clin. Endocrinol. Metab. 2003; 88(1): 277-84.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2017 Eco-Vector


СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: 

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies